Miltefosine

Records for this ingredient, by country (identity only).

ATC L01XX09 · 3 markets · 5 records

Miltefosine 3 markets · 5 records Forms

Filters

MarketUS 2 GB 2

Strength

US 2 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

50 mgcapsuleIMPAVIDO also in GB

GB 2 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

50 mgcapsuleIMPAVIDO also in US
10 mgcapsuleIMPAVIDO

Side-by-side table

Strength / form / release	US	GB
50 mg capsule	IMPAVIDO	IMPAVIDO
10 mg capsule	not recorded	IMPAVIDO

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.